fosinopril has been researched along with Myocardial Infarction in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 14 (58.33) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, X; Chen, P; Gao, X; Ge, F; Huang, L; Huang, M; Jiao, S; Li, J; Liu, J; Tu, P; Wuken, S | 1 |
| Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A | 1 |
| Deng, ZJ; Fu, YH; Guo, JW; Li, LM; Liu, RX; Pan, JQ; Qiu, GQ; Yang, M | 1 |
| Bicket, DP | 1 |
| Agaev, MM; Azizov, VA | 1 |
| Lai, KN; Lam, KY; Leung, JC; Li, PS; Wing-Hon Lai, K; Yu, CM | 1 |
| Gu, SM; Wei, M; Wu, YH; Wu, ZG; Zhang, YY | 1 |
| Borghi, C; de Kam, PJ; Hochman, JS; van den Berg, MP; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Huang, YL; Sun, YH; Zhang, RY | 1 |
| Chen, JL; Chen, ZJ; Gao, RL; Jing, ZC; Meng, L; Tian, Y; Wu, YJ; Yang, WX; Yang, YJ; You, SJ; Zhao, JL | 1 |
| Cheng, JL; Gao, RL; Jing, ZC; Wu, YJ; Yang, YJ; You, SJ; Zhao, JL | 1 |
| Chen, JL; Gao, RL; Pei, WD; Sun, YH; Yang, YJ; Zhang, YH; Zhao, JL | 1 |
| Agaev, MM | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C | 1 |
| Ambrosioni, E; Borghi, C; Collatina, S; Magnani, B; Marino, P; Zardini, P | 2 |
| Altmann, C; Horstmann, E; Josephs, W; Konermann, M; Laschewski, F; Odenthal, HJ; Sanner, B | 1 |
| Ambrosioni, E; Anselmi, M; Borghi, C; Golia, G; Marino, P; Zanolla, L; Zardini, P | 1 |
| Aĭrapetian, G; Ter-Grigorian, V | 1 |
| Ellsworth, A; Fink, KS | 1 |
| Altmann, C; Konermann, M; Laschewski, F; Odenthal, HJ; Rawert, B; Sanner, BM; Trappe, HJ | 1 |
| Altmann, C; Konermann, M; Laschewski, F; Rawert, B; Sanner, BM; Trappe, HJ | 1 |
| Lau, CP; Tipoe, GL; Wing-Hon Lai, K; Yu, CM | 1 |
| Beck, L; Blanc-Guillemaud, V; Cherif, OK; Davy, JM; Jover, B | 1 |
2 review(s) available for fosinopril and Myocardial Infarction
| Article | Year |
|---|---|
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
The use of zofenopril and fosinopril in acute myocardial infarction and carotid artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Captopril; Carotid Artery Diseases; Clinical Trials as Topic; Fosinopril; Humans; Myocardial Infarction | 1994 |
8 trial(s) available for fosinopril and Myocardial Infarction
| Article | Year |
|---|---|
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fibrinolytic Agents; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Recurrence; Risk Factors; Survival Analysis; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2005 |
[Clinical efficiency of the use of monopril, propanolol and heparinum in stationary rehabilitation of patients with myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Fibrinolytic Agents; Fosinopril; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Propranolol | 2008 |
Post acute myocardial infarction: the Fosinopril in Acute Myocardial Infarction Study (FAMIS).
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Cardiac Volume; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Fosinopril; Heart Rate; Humans; Male; Myocardial Infarction; Thrombolytic Therapy; Ventricular Function, Left | 1997 |
Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatine Kinase; Female; Follow-Up Studies; Fosinopril; Heart Ventricles; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Organ Size; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 1998 |
Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cause of Death; Double-Blind Method; Drug Administration Schedule; Echocardiography; Female; Follow-Up Studies; Fosinopril; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Stroke Volume; Survival Rate; Thrombolytic Therapy; Tissue Plasminogen Activator | 1998 |
The extent of regional wall motion abnormalities identifies patients at risk of extensive left ventricular remodeling: implications for the design of post myocardial infarction trials.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Data Interpretation, Statistical; Double-Blind Method; Echocardiography; Female; Follow-Up Studies; Fosinopril; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Time Factors; Ventricular Remodeling | 1999 |
[Effect of ACE-inhibitors on left ventricular remodeling after acute anterior or posterior myocardial infarct. Cine- magnetic resonance tomography study].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Stroke Volume; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2000 |
Is the tissue affinity of ACE inhibitors of relevance for the remodeling of the left ventricular wall following myocardial infarction? Estimations with cine magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fosinopril; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left; Ventricular Remodeling | 2000 |
14 other study(ies) available for fosinopril and Myocardial Infarction
| Article | Year |
|---|---|
Zerumbone, a humulane sesquiterpene from Syringa pinnatifolia, attenuates cardiac fibrosis by inhibiting of the TGF-β1/Smad signaling pathway after myocardial infarction in mice.
Topics: Animals; Collagen Type I; Fibrosis; Fosinopril; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction; Smad Proteins; Syringa; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2022 |
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, Animal; Exercise Tolerance; Fosinopril; Glucosides; Heart Failure; Male; Myocardial Infarction; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
[Effects of Panax notoginseng saponins on ACE2 and TNF-alpha in rats with post-myocardial infarction-ventricular remodeling].
Topics: Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Disease Models, Animal; Female; Fosinopril; Glutathione Peroxidase; Male; Malondialdehyde; Myocardial Infarction; Myocardium; Nitric Oxide; Panax notoginseng; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; Saponins; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2010 |
[Efficacy of combined use of fosinopril and propranolol in acute myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diastole; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler; Electrocardiography; Fosinopril; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Propranolol; Systole; Vasodilator Agents; Ventricular Function, Left | 2003 |
Normalization of renal aquaporin-2 water channel expression by fosinopril, valsartan, and combination therapy in congestive heart failure: a new mechanism of action.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Aquaporin 2; Aquaporins; Drug Therapy, Combination; Fosinopril; Gene Expression; Heart Failure; Kidney Cortex; Kidney Medulla; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2004 |
[Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Therapy, Combination; Fosinopril; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Pravastatin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2005 |
[Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Drug Synergism; Fosinopril; Irbesartan; Male; Myocardial Infarction; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Ventricular Remodeling | 2005 |
[Beneficial effects of fosinopril on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
Topics: Animals; Blood Flow Velocity; Disease Models, Animal; Female; Fosinopril; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Swine; Swine, Miniature | 2005 |
Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion.
Topics: Acute Disease; Animals; Antihypertensive Agents; Blood Flow Velocity; Chemoprevention; Endothelium; Fosinopril; H(+)-K(+)-Exchanging ATPase; Models, Animal; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Swine; Tetrazoles; Time Factors; Valine; Valsartan | 2006 |
Chronic pretreatment of ACEI reduces no-reflow in patients with acute myocardial infarction treated with primary angioplasty.
Topics: Adult; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Captopril; Coronary Angiography; Coronary Circulation; Electrocardiography; Enalapril; Female; Fosinopril; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Research Design; Stroke Volume; Time Factors; Treatment Outcome | 2007 |
[Early application of angiotensin converting enzyme inhibitors in acute myocardial infarction].
Topics: Angiotensin-Converting Enzyme Inhibitors; Coronary Care Units; Echocardiography; Enalapril; Exercise Test; Follow-Up Studies; Fosinopril; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Stroke Volume; Time Factors; Treatment Outcome | 1999 |
Antihypertensive treatment and CHD in the elderly.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Complications; Double-Blind Method; Felodipine; Fosinopril; Humans; Hypertension; Myocardial Infarction; Nisoldipine; Nitrendipine; Randomized Controlled Trials as Topic | 1999 |
Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Collagen; Drug Combinations; Fibrosis; Fosinopril; Male; Myocardial Infarction; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Valine; Valsartan; Ventricular Remodeling | 2001 |
Effects of spironolactone and fosinopril on the spontaneous and chronic ventricular arrhythmias in a rat model of myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Chronic Disease; Disease Models, Animal; Electrocardiography, Ambulatory; Fosinopril; Heart Rate; Heart Ventricles; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Random Allocation; Rats; Rats, Wistar; Spironolactone; Time Factors; Ventricular Dysfunction; Ventricular Premature Complexes | 2001 |